Daclizumab beta may be superior to interferon beta on MS disability progressionJanuary 8, 2019Multiple Sclerosis
Does rituximab delay disability progression in patients with secondary progressive MS?January 7, 2019Multiple Sclerosis
Real-world data reveal long-lasting effects achieved with RRMS treatmentsDecember 13, 2018Multiple Sclerosis
Virus-Specific T-Cell Infusions May Resolve Progressive Multifocal LeukoencephalopathyDecember 11, 2018Multiple Sclerosis
Stroke, arterial dissection events reported with Lemtrada, FDA saysNovember 29, 2018Multiple Sclerosis
Particular lesions early after CIS predict long-term MS disabilityNovember 27, 2018Multiple Sclerosis
Panel Provides Recommendations for Managing Cognitive Changes in MSNovember 16, 2018Multiple Sclerosis
MS disease activity returns in one-third after fingolimod withdrawalNovember 15, 2018Multiple Sclerosis
Anti-MOG antibodies associated with non-MS, monophasic demyelinating disease in young childrenNovember 15, 2018Multiple Sclerosis
